MIRACLE Medical Technology Act of 2025

# MIRACLE Medical Technology Act of 2025 (HR 661) Summary **What the Bill Does:** This bill would establish a formal partnership between the U.S. Department of Health and Human Services (HHS) and Israel to jointly develop and improve healthcare products and services. The collaboration would focus on research, new medical technology, protecting patents and intellectual property, streamlining regulations between the two countries, disease prevention, and manufacturing of biological products (like vaccines and biologics).

The bill also authorizes creating a joint U.S.-Israel Health Care Collaboration Center in the United States to coordinate these efforts and share expertise. **Who It Affects:** The bill primarily affects medical researchers, pharmaceutical and medical device companies, healthcare professionals, and patients who could potentially benefit from faster development and approval of new treatments. It also involves government agencies and officials in both countries responsible for healthcare and scientific research. **Current Status:** HR 661 is currently in committee review (as of early 2025), meaning it has been introduced but has not yet advanced to a full vote in the House of Representatives. The bill was sponsored by Representative Vern Buchanan (R-FL).